Atrion

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Atrion Corporation is a supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets.

Atrion is a long-term value creator which has lost a third of its value over the past eighteen months. This correction should be seen in the light of the long-term share price developments, as the company continued to see steady growth.

Atrion: A Potential Healthy Addition To The Portfolio

American Financial Group

Bank OZK

Intuit

Johnson Outdoors

Firms increasing their dividends in 2020, of all years, are sending a powerful “payout confidence” signal to Wall Street.

5 Fast-Growing Dividends Up To 24% Per Year

ABM Industries

Accenture Plc

Acme United

Automatic Data Processing

Albemarle

Allstate

Andersons

Air Products and Chemicals

Alexandria Real Estate Equities

Artesian Resources

Broadcom

Axis Capital

BancFirst

Becton, Dickinson and Co.

Franklin Resources

Brookfield Renewable Partners

Brookfield Infrastructure Partners L.P.

Bristol-Myers

Broadridge Financial

Cardinal Health

C.H. Robinson Worldwide

Comerica

Canadian National Railway Company

American Tower

A weekly summary of dividend activity for Dividend Champions and Contenders.

Dividend Champion And Contender Highlights: Week Of September 27

Community Bank System

Community Trust Bancorp

Logitech

Altria

National Storage Affiliates Trust

Worthington Industries

7 Upcoming Dividend Increases Including This Dividend King

Lowe's

Polaris

Dividend Changes: August 15-21, 2020

ALLEN, Texas, Aug.  20, 2020  (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.55 per share to $1.75 per share. Specifically, the Board of Directors declared a quarterly dividend of $1.75 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2020 to stockholders of record at the close of business on September 15, 2020.

Atrion Corporation Increases Quarterly Cash Dividend by 13%

Chemed

Omega Flex

Rollins

“The greatest companies in lousy industries share certain characteristics. They are low-cost operators and penny-pinchers in the executive suite.

An Annual Review on the CORA portfolio

ALLEN, Texas, Feb.  26, 2020  (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.55 per share on its outstanding shares of Common Stock.  This dividend will be payable on March 31, 2020 to stockholders of record at the close of business on March 16, 2020.  Atrion Corporation develops and manufactures products primarily for medical applications.  The Company’s website is www.atrioncorp.com.

Atrion Corporation Declares  Quarterly Cash Dividend

Atrion Corp.: Mini Share Price Uptick Indicative Of Further Gains

Corcept Therapeutics

Merit Medical Systems

National Research Corp

Supernus Pharmaceuticals

According to the GuruFocus All-In-One Screener as of Friday, the following health care stocks are popular among gurus.

5 Health Care Stocks - Gurus Are Buying

ALLEN, Texas, Aug.  19, 2019  (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.35 per share to $1.55 per share.  Specifically, the Board of Directors declared a quarterly dividend of $1.55 per share on its outstanding shares of Common Stock.  This dividend will be payable on September 30, 2019 to stockholders of record at the close of business on September 16, 2019.

Atrion Corporation Increases Quarterly Cash Dividend by 15%

AutoZone

Cable One

White Mountains Insurance Group

According to the GuruFocus All-in-One Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the last 12 months.

5 Companies Outperforming the Market

News for Atrion Stock (ATRI)